El-Nasir Lalani - Pakistan
Aga Khan University
Professor El-Nasir Lalani is the Founding Director of the Aga Khan University Centre for Regenerative Medicine and Stem Cell Research (AKU-CRM), a position to which he was appointed in 2016. The stem cell research program at the AKU-CRM is developed in partnership with the Eli and Edythe Broad Centre for Regeneration Medicine at University of California, San Francisco. He is the Executive Committee Chair of the AKU-CRM and UCSF Research Capacity Development Program.
Dr Lalani is a Professor of Stem Cell Biology & Translational Medicine with a cross appointment in the Department of Pathology and Laboratory Medicine as Professor of Molecular & Cellular Pathology at Aga Khan University. He received his BSc (Hons) from University of Dundee, MBChB from University of Edinburgh, and PhD from University College, London, UK.
Dr Lalani is a Fellow of the Royal College of Pathologists and the Higher Education Academy, UK. He served as Director of the Pakistan Medical and Research Council, member of the Department of Health (UK) Human Tissue Authority, and member of various national and international ethics committees.
He was the Founding Dean of Research and Graduate Studies at the Aga Khan University, a post he held for eight years. Prior to joining AKU, he was the Robert Leith Professor of Pathology and Head of the Department of Pathology at the University of Birmingham, UK. Before that, he was the Professor of Molecular & Cellular Pathology and Deputy Head of the Department of Pathology, Imperial College London, UK.
Dr Lalani has served as Co-Director of the Imperial College (adult) and MRC (foetal) Human Biomaterial Resource Centre (HBRC) and was the Human Tissue Authority Designated Individual at the University of Birmingham, UK.
He has numerous papers, book chapters and books to his credit. His research work spans the fields of basic science and clinical medicine. His academic career and expertise include stem cell and cancer biology, pathology, bio-banking and bioethics. His research interests are in stem cell biology (liver and cancer), epithelial cell biology, molecular pathology, and prostate & breast cancer.